After $371M merger, what comes next for LabCorp and Sequenom?
The two companies are perched on a risky, competitive genetic testing market valued in 2015 at $3 billion.
The two companies are perched on a risky, competitive genetic testing market valued in 2015 at $3 billion.
Genetic analysis company Sequenom (NASDAQ:SQNM) has chosen Research Triangle Park, North Carolina to build up its newer molecular diagnostics unit, which the company expects could become its biggest business. The Sequenom Center for Molecular Medicine is set to open in the second half of 2012 and will focus on developing diagnostics for prenatal diseases and […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Sequenom Inc. (NASDAQ:SQNM) this week became the latest genomics firm to raise money with an $84 million public offering. The San Diego-based company develops molecular diagnostics technologies for "translational research, oncology, agricultural genomics and in vitro diagnostics for prenatal and retinal disorders," according to its website.